{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:14Z","timestamp":1790757374626,"version":"4.1.0"},"reference-count":31,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck KGaA, Darmstadt, Germany","award":["10.13039\/100009945"],"award-info":[{"award-number":["10.13039\/100009945"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,6,17]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Evidence is scarce concerning the impact on postpartum relapse activity of disease-modifying therapy (DMT) use during pregnancy after assisted reproductive technology (ART) treatment. We investigated relapse activity before pregnancy, during pregnancy and 3 and 12\u2009months postpartum overall and according to DMT exposure during pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Women with relapsing-remitting multiple sclerosis (MS) from the Danish MS Registry who gave birth after ART from 1995 to 2018 were eligible for inclusion. Annualised relapse rate (ARR) before pregnancy, during pregnancy and postpartum was evaluated using a negative binomial regression model with relapse count as the dependent variable overall and according to DMT exposure during pregnancy. Logistic regression was used to identify predictors of being relapse-free 12 months postpartum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 111\u2009women, median age 32 years (IQR: 29\u201335), were included. Overall, ARR (95%\u2009CI) was 0.14 (0.08 to 0.24) before pregnancy, 0.13 (0.07 to 0.25) during pregnancy and 0.33 (0.17 to 0.61) 3 months postpartum; rate ratio difference between before pregnancy and postpartum was 2.42 (1.03 to 5.67), and between during pregnancy and postpartum was 2.46 (1.18 to 5.13). Age \u226535 years and no DMT exposure before pregnancy were predictors of being relapse-free 12 months postpartum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Relapse activity was more than two times higher 3 months postpartum than before and during pregnancy. Stratified for DMT exposure during pregnancy, rate ratios were similar and did not reach statistical significance. Postpartum relapse activity more than doubled from both low ARR (unexposed to DMT during pregnancy) and higher ARR (exposed to DMT during pregnancy) pre-pregnancy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001092","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T23:55:19Z","timestamp":1751586919000},"page":"e001092","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Disease-modifying therapy during pregnancy and postpartum relapse activity in women with multiple sclerosis undergoing assisted reproductive technology treatment: a nationwide cohort study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-6457","authenticated-orcid":false,"given":"Lene","family":"von Kappelgaard","sequence":"first","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-3954","authenticated-orcid":false,"given":"Elisabeth","family":"Framke","sequence":"additional","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Vassard","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Enrique","family":"Schwarze","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-6759","authenticated-orcid":false,"given":"Meritxell","family":"Sabid\u00f3","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-5222","authenticated-orcid":false,"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2025072811193712000_7.2.e001092.1","unstructured":"Women living with multiple sclerosis New York. 2024. Available: https:\/\/www.nationalmssociety.org\/understanding-ms\/what-is-ms\/who-gets-ms\/women-with-ms"},{"key":"2025072811193712000_7.2.e001092.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102541"},{"key":"2025072811193712000_7.2.e001092.3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/1352458519851245","article-title":"Reproductive history of the Danish multiple sclerosis population: A register-based study","volume":"26","author":"Moberg","year":"2020","journal-title":"Mult Scler"},{"key":"2025072811193712000_7.2.e001092.4","doi-asserted-by":"crossref","first-page":"103980","DOI":"10.1016\/j.rbmo.2024.103980","article-title":"Is infertility more common among patients with multiple sclerosis? Implications for utilization of assisted reproductive techniques","volume":"49","author":"Skvirsky","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"2025072811193712000_7.2.e001092.5","first-page":"28","article-title":"Multiple sclerosis: pregnancy and motherhood","volume":"16","author":"Anderson","year":"2013","journal-title":"Pract Midwife"},{"key":"2025072811193712000_7.2.e001092.6","first-page":"2","article-title":"Pregnancy and Motherhood Concerns Surrounding Women with Multiple Sclerosis: A Qualitative Content Analysis","volume":"8","author":"Ghafoori","year":"2020","journal-title":"Int J Community Based Nurs Midwifery"},{"key":"2025072811193712000_7.2.e001092.7","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.620772","article-title":"Family Planning Decision Making in People With Multiple Sclerosis","volume":"12","author":"Bonavita","year":"2021","journal-title":"Front Neurol"},{"key":"2025072811193712000_7.2.e001092.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00426-4"},{"key":"2025072811193712000_7.2.e001092.9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-023-01036-1","article-title":"Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis","volume":"37","author":"Sparaco","year":"2023","journal-title":"CNS Drugs"},{"key":"2025072811193712000_7.2.e001092.10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2022.10.027","article-title":"Assisted reproductive technology treatment and risk of multiple sclerosis - a Danish cohort study","volume":"119","author":"Kopp","year":"2023","journal-title":"Fertil Steril"},{"key":"2025072811193712000_7.2.e001092.11","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoac022","article-title":"ART in Europe, 2018: results generated from European registries by ESHRE","volume":"2022","author":"Wyns","year":"2022","journal-title":"Hum Reprod Open"},{"key":"2025072811193712000_7.2.e001092.12","unstructured":"Family planning and pregnancy with multiple sclerosis New York. 2024. Available: https:\/\/www.nationalmssociety.org\/managing-ms\/living-with-ms\/diet-exercise-and-healthy-behaviors\/pregnancy"},{"key":"2025072811193712000_7.2.e001092.13","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211051012","article-title":"A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis","volume":"14","author":"Hellwig","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"2025072811193712000_7.2.e001092.14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331525"},{"key":"2025072811193712000_7.2.e001092.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104122"},{"key":"2025072811193712000_7.2.e001092.16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330533"},{"key":"2025072811193712000_7.2.e001092.17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513507816"},{"key":"2025072811193712000_7.2.e001092.18","first-page":"e1939","article-title":"Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort","volume":"94","author":"Langer-Gould","year":"2020","journal-title":"Neurology (ECronicon)"},{"key":"2025072811193712000_7.2.e001092.19","doi-asserted-by":"crossref","first-page":"105738","DOI":"10.1016\/j.msard.2024.105738","article-title":"Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis","volume":"88","author":"Bove","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025072811193712000_7.2.e001092.20","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200253","article-title":"Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths","volume":"14","author":"Graham","year":"2024","journal-title":"Neurol Clin Pract"},{"key":"2025072811193712000_7.2.e001092.21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/WCO.0000000000001275","article-title":"Pregnancy and reproductive health in women with multiple sclerosis: an update","volume":"37","author":"Houtchens","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"2025072811193712000_7.2.e001092.22","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1921","article-title":"The Danish Multiple Sclerosis Registry","volume":"11","author":"Magyari","year":"2021","journal-title":"Brain Behav"},{"key":"2025072811193712000_7.2.e001092.23","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"2025072811193712000_7.2.e001092.24","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2025072811193712000_7.2.e001092.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00742-8"},{"key":"2025072811193712000_7.2.e001092.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0356-1"},{"key":"2025072811193712000_7.2.e001092.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-024-01483-4","article-title":"Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles\u2019 outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study","volume":"17","author":"Arabipoor","year":"2024","journal-title":"J Ovarian Res"},{"key":"2025072811193712000_7.2.e001092.28","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519866613"},{"key":"2025072811193712000_7.2.e001092.29","doi-asserted-by":"publisher","DOI":"10.1177\/1756285616631897"},{"key":"2025072811193712000_7.2.e001092.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.04.003"},{"key":"2025072811193712000_7.2.e001092.31","first-page":"125","article-title":"Disease-modifying therapy during pregnancy and occurrence of post-partum relapses in women with multiple sclerosis: a register-based study among women undergoing assisted reproductive technology treatment","volume":"30","author":"von Kappelgaard","year":"2024","journal-title":"Mult Scler"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:19:46Z","timestamp":1753726786000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,3]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001092"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001092","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}